Clinical trials with compound L6842, a new anthelminthic agent.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000724:Ancylostomiasis / Q000188:drug therapy; D000871:Anthelmintics; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D006925:Hymenolepiasis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013622:Taeniasis / Q000188:drug therapy; D013861:Thiocyanates / Q000008:administration & dosage / Q000627:therapeutic use*; D014257:Trichuriasis / Q000188:drug therapy
D000871:Anthelmintics; D001555:Benzene Derivatives; D013861:Thiocyanates